172 related articles for article (PubMed ID: 36344968)
21. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
[TBL] [Abstract][Full Text] [Related]
22. The joint association of diabetes status and NT-ProBNP with adverse cardiac outcomes in patients with non-ST-segment elevation acute coronary syndrome: a prospective cohort study.
Wang M; Su W; Chen H; Li H
Cardiovasc Diabetol; 2023 Mar; 22(1):46. PubMed ID: 36871021
[TBL] [Abstract][Full Text] [Related]
23. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
Li YY; Liang YD; Yao SM; Zheng PP; Zeng XZ; Cui LL; Guo D; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):661-668. PubMed ID: 32847322
[No Abstract] [Full Text] [Related]
24. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study.
Liu HH; Cao YX; Jin JL; Guo YL; Zhu CG; Wu NQ; Gao Y; Zhang Y; Xu RX; Dong Q; Li JJ
Cardiovasc Diabetol; 2021 Apr; 20(1):84. PubMed ID: 33888145
[TBL] [Abstract][Full Text] [Related]
26. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Elevated NT-proBNP and its Prognostic Value by Blood Pressure Treatment and Control.
Daya NR; McEvoy JW; Christenson RH; Tang O; Foti K; Juraschek SP; Selvin E; Echouffo-Tcheugui JB
Am J Hypertens; 2023 Oct; 36(11):602-611. PubMed ID: 37458697
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality.
van den Broek KC; Defilippi CR; Christenson RH; Seliger SL; Gottdiener JS; Kop WJ
Am J Cardiol; 2011 Mar; 107(5):723-9. PubMed ID: 21316507
[TBL] [Abstract][Full Text] [Related]
29. CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.
Konev AA; Kharitonov AV; Rozov FN; Altshuler EP; Serebryanaya DV; Lassus J; Harjola VP; Katrukha AG; Postnikov AB
ESC Heart Fail; 2020 Apr; 7(2):434-444. PubMed ID: 31967738
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
32. Association of N-terminal pro-brain natriuretic peptide level with adverse outcomes in patients with acute myocardial infarction: A meta-analysis.
Shen S; Ye J; Wu X; Li X
Heart Lung; 2021; 50(6):863-869. PubMed ID: 34340134
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
Butt JH; Adamson C; Docherty KF; de Boer RA; Petrie MC; Inzucchi SE; Kosiborod MN; Maria Langkilde A; Lindholm D; Martinez FA; Bengtsson O; Schou M; O'Meara E; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV; Køber L
Circ Heart Fail; 2021 Dec; 14(12):e008837. PubMed ID: 34802253
[TBL] [Abstract][Full Text] [Related]
34. NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.
Di Castelnuovo A; Veronesi G; Costanzo S; Zeller T; Schnabel RB; de Curtis A; Salomaa V; Borchini R; Ferrario M; Giampaoli S; Kee F; Söderberg S; Niiranen T; Kuulasmaa K; de Gaetano G; Donati MB; Blankenberg S; Iacoviello L;
Stroke; 2019 Mar; 50(3):610-617. PubMed ID: 30786848
[TBL] [Abstract][Full Text] [Related]
35. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation.
Fu S; Jiao J; Guo Y; Zhu B; Luo L
BMC Geriatr; 2019 Feb; 19(1):56. PubMed ID: 30819103
[TBL] [Abstract][Full Text] [Related]
36. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
Schou M; Gustafsson F; Corell P; Kistorp CN; Kjaer A; Hildebrandt PR
Am Heart J; 2007 Jul; 154(1):123-9. PubMed ID: 17584564
[TBL] [Abstract][Full Text] [Related]
37. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
38. Serial measurements of N-terminal pro-brain natriuretic peptide in patients with coronary heart disease.
Dallmeier D; Pencina MJ; Rajman I; Koenig W; Rothenbacher D; Brenner H
PLoS One; 2015; 10(1):e0117143. PubMed ID: 25629613
[TBL] [Abstract][Full Text] [Related]
39. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
Eggers KM; Venge P; Lind L
Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
[TBL] [Abstract][Full Text] [Related]
40. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
